Literature DB >> 9817190

Interactions of cyclosporin A and amlodipine: blood cyclosporin A levels, hypertension and kidney function.

Y C Schrama1, H A Koomans.   

Abstract

The introduction of cyclosporin A has led to improved survival of allografts in humans. However, the use of cyclosporin A is associated with an increased prevalence of hypertension in kidney transplant recipients. Renal vasoconstriction and enhancement of tubular reabsorption contribute to this hypertensive effect. Concomitant treatment with calcium channel blockers blocks or ameliorates most of these adverse effects. This paper reviews the short-term effects of the calcium channel blocker amlodipine on plasma levels of cyclosporin A and its interaction with blood pressure and kidney function.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9817190

Source DB:  PubMed          Journal:  J Hypertens Suppl        ISSN: 0952-1178


  3 in total

1.  Cyclosporin enhances the tendency towards oedema and flushing noted on dihydropyridine calcium channel blockers.

Authors:  R O von Vigier; E Fossali; A Edefonti; B Vogt; M G Bianchetti
Journal:  Br J Clin Pharmacol       Date:  2002-09       Impact factor: 4.335

2.  Benefit of theophylline administration in tacrolimus-induced nephrotoxicity in rats.

Authors:  Gwenn E McLaughlin; Michelle Schober; Maria Perez; Phillip Ruiz; Bernard W Steele; Carolyn Abitbol
Journal:  Pediatr Nephrol       Date:  2003-06-26       Impact factor: 3.714

3.  Tacrolimus dose requirement in renal transplant recipients is significantly higher when used in combination with corticosteroids.

Authors:  Dennis A Hesselink; Hien Ngyuen; Marike Wabbijn; Peter J H Smak Gregoor; Ewout W Steyerberg; Iza C van Riemsdijk; Willem Weimar; Teun van Gelder
Journal:  Br J Clin Pharmacol       Date:  2003-09       Impact factor: 4.335

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.